Literature DB >> 23168877

Evaluation of microalbuminuria in relation to asymptomatic bacteruria in Nigerian patients with sickle cell anemia.

B A Iwalokun1, S O Iwalokun, S O Hodonu, O A Aina, P U Agomo.   

Abstract

Studies have identified microalbuminuria (MA) and asymptomatic bacteruria (ASB) as co-morbid factors in sickle cell anemia (SCA). However, the relationship between these comorbid factors remains unclear and data are lacking for Nigerian patients. This study determined the prevalence of MA and ASB in a cohort of patients with SCA in a steady state, in Lagos, Nigeria. Early morning mid-stream urine samples were collected in sterile bottles from 103 patients comprising 48 males and 55 females with a mean age of 10.4 years. Aerobic culture and colony count of organisms was done using conventional methods. Serum creatinine and hematological indices, including irreversibly sickled cells (ISC), were also assayed. Of the 103 urine samples screened, 23 (22.3%) had albuminuria (ALB), and consisted of nine males and 14 females (P > 0.05); 16.5% of the cases had MA (P <0.05). Age at onset of MA was seven years, and children accounted for 23.5% of all cases with ALB (P >0.05). The prevalence of confirmed ASB was 14.6%, with females accounting for 14 of 19 probable ASB cases (P <0.05). Univariate regression analysis demonstrated a significant (P <0.05) association between age at onset of MA, hemoglobin level, reticulocyte count, ISC and occurrence of ASB, but with only ISC evolving as an independent predictor. Twenty-eight bacterial isolates predominated by Escherichia coli (39.3%; P <0.05), of whom 89.3% were multi-drug resistant, were recovered from the ASB urine samples. In conclusion, both MA and ASB are common in Nigerian SCA patients, with the former occurring from the first decade of life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168877     DOI: 10.4103/1319-2442.103589

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  9 in total

1.  Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.

Authors:  Ashley Thrower; Emily J Ciccone; Poulami Maitra; Vimal K Derebail; Jianwen Cai; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2018-11-21       Impact factor: 6.998

2.  Prevalence of Asymptomatic Bacteriuria in Hospitalized Patients.

Authors:  Sergio E Trevino; Jeffrey P Henderson; Jiami Wu; Candice Cass; Jonas Marschall
Journal:  Infect Control Hosp Epidemiol       Date:  2016-03-17       Impact factor: 3.254

Review 3.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

Review 4.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10

Review 5.  The glomerulopathy of sickle cell disease.

Authors:  Kenneth I Ataga; Vimal K Derebail; David R Archer
Journal:  Am J Hematol       Date:  2014-06-19       Impact factor: 10.047

6.  Degrees of kidney disease in nigerian adults with sickle-cell disease.

Authors:  John C Aneke; Adegbola O Adegoke; Anthony A Oyekunle; Patrick O Osho; Abubakra A Sanusi; Emmanuel C Okocha; Nancy C Ibeh; Norah O Akinola; Muheez A Durosinmi
Journal:  Med Princ Pract       Date:  2014-04-16       Impact factor: 1.927

Review 7.  Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients.

Authors:  Ambroise Wonkam; Julie Makani; Solomon Ofori-Aquah; Obiageli E Nnodu; Marsha Treadwell; Charmaine Royal; Kwaku Ohene-Frempong
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 0.802

8.  Prevalence and determinants of microalbuminuria in children suffering from sickle cell anemia in steady state.

Authors:  Michel N Aloni; Jean-Louis L Mabidi; René M Ngiyulu; Pépé M Ekulu; Fiston I Mbutiwi; Jean Robert Makulo; Ernest K Sumaili; Jean Lambert Gini-Ehungu; Célestin N Nsibu; Nazaire M Nseka; François B Lepira
Journal:  Clin Kidney J       Date:  2017-07-12

9.  Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis.

Authors:  Kenneth I Ataga; Victor R Gordeuk; Irene Agodoa; Jennifer A Colby; Kimberly Gittings; Isabel E Allen
Journal:  PLoS One       Date:  2020-04-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.